Skip to main content

Advertisement

SpringerLink
Log in

The utility of muscle biopsy

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Despite major advances in molecular genetics, histopathologic evaluation of muscle biopsy specimens continues to provide important diagnostic information in patients with suspected muscle diseases and in patients with vasculitic neuropathies. Muscle biopsy specimens are used in diagnosing many inherited as well as inflammatory and toxic myopathies. Furthermore, the study of muscle histopathology can also enhance our understanding of disease pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lacomis D: Electrodiagnostic approach to the patient with suspected myopathy. Neurol Clin 2002, 20:587–603.

    Article  PubMed  Google Scholar 

  2. Buchthal F, Kamieniecka Z: The diagnostic yield of quantified electromyography and quantified muscle biopsy in neuromuscular disorders. Muscle Nerve 1982, 5:265–280.

    Article  PubMed  CAS  Google Scholar 

  3. Campellone JV, Lacomis D, Giuliani MJ, Oddis CV: Percutaneous needle muscle biopsy in the evaluation of patients with suspected inflammatory myopathy. Arthritis Rheum 1997, 40:1886–1891.

    Article  PubMed  CAS  Google Scholar 

  4. Dorph C, Nennesmo I, Lundberg IE: Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool. J Rheumatol 2001, 28:1591–1599.

    PubMed  CAS  Google Scholar 

  5. Laguno M, Miró O, Perea M, et al.: Muscle diseases in elders: a 10-year retrospective study. J Gerontol Med Sci 2002, 57A:M378-M384.

    Google Scholar 

  6. Dabby R, Lange DJ, Trojaborg W, et al.: Inclusion body myositis mimicking motor neuron disease. Arch Neurol 2001, 58:1253–1256.

    Article  PubMed  CAS  Google Scholar 

  7. Miller T, Al-Lozi MT, Lopate G, Pestronk A: Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 2002, 73:420–428.

    Article  PubMed  CAS  Google Scholar 

  8. Gherardi RK, Coquet M, Cherin P, et al.: Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle. Brain 2001, 124:1821–1831. The authors provide a comprehensive histopathologic evaluation of specimens from patients with macrophagic myofasciitis. Light microscopy and ultrastructural studies, as well as microanalytical studies, are utilized in conjunction with clinical evaluations to show that intramuscular injections of aluminum hydroxide-containing vaccines trigger this process.

    Article  PubMed  CAS  Google Scholar 

  9. Zivkovic SA, Lacomis D, Clemens PR: Chronic eosinophilic perimyositis with persistent myalgias. Muscle Nerve 2002, 25:461–465.

    Article  PubMed  Google Scholar 

  10. Kobayashi Y, Fujimoto T, Shiiki H, et al.: Focal eosinophilic myositis. Clin Rheumatol 2001, 20:369–371.

    Article  PubMed  CAS  Google Scholar 

  11. Kisielinski K, Miltner O, Sellhaus B, et al.: Recurrent focal myositis of the peroneal muscles. Rheumatology 2002, 41:1318–1322.

    Article  PubMed  CAS  Google Scholar 

  12. McNeil SM, Woulfe J, Ross C, Tarnopolsky MA: Congenital inflammatory myopathy: a demonstrative case and proposed diagnostic classification. Muscle Nerve 2002, 25:259–264.

    Article  PubMed  Google Scholar 

  13. Messina S, Fagiolari G, Lamperti C, et al.: Women with pregnancy-related polymyositis and high serum CK levels in the newborn. Neurology 2002, 58:482–484.

    PubMed  CAS  Google Scholar 

  14. Prayson RA: Skeletal muscle vasculitis exclusive of inflammatory myopathic conditions: a clinicopathologic study of 40 patients. Hum Pathol 2002, 33:989–995.

    Article  PubMed  Google Scholar 

  15. Plumley SG, Rubio R, Alasfar S, Jasin HE: Polyarteritis nodosa presenting as polymyositis. Semin Arthritis Rheum 2002, 31:377–383.

    Article  PubMed  Google Scholar 

  16. De Jonghe B, Sharshar T, Lefaucheur JP, et al.: Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288:2859–2867.

    Article  PubMed  Google Scholar 

  17. Campellone JV, Lacomis D, Kramer DJ, et al.: Acute myopathy after liver transplantation. Neurology 1998, 50:46–53.

    PubMed  CAS  Google Scholar 

  18. Perea M, Picón M, Miró O, et al.: Acute quadriplegic myopathy with loss of thick (myosin) filaments following heart transplantation. J Heart Lung Transplant 2001, 20:1136–1141.

    Article  PubMed  CAS  Google Scholar 

  19. Trojaborg W, Weimer LH, Hays AP: Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy— a reappraisal. Clin Neurophysiol 2001, 112:1586–1593. Critically ill patients can develop both critical illness myopathy and critical illness polyneuropathy. When these conditions occur together, it is of interest to know which component is the major cause of weakness. The authors performed an extensive electrophysiologic study in 22 consecutive patients with critical illness and weakness and they correlated the findings with muscle biopsies from nine patients. This study strongly suggests that myopathy is more common than polyneuropathy in critical illness, and even when electrophysiologic features of polyneuropathy were present, biopsy and muscle excitability findings were more consistent with critical illness myopathy.

    Article  PubMed  CAS  Google Scholar 

  20. Mahjneh I, Marconi G, Paetau A, et al.: Axial myopathy—an unrecognized entity. J Neurol 2002, 249:730–734.

    Article  PubMed  Google Scholar 

  21. Muntoni F: Is a muscle biopsy in Duchenne dystrophy really necessary? Neurology 2001, 57:574–575.

    PubMed  CAS  Google Scholar 

  22. Ladwig D, Mowat D, Tobias V, et al.: In utero fetal muscle biopsy in the diagnosis of Duchenne muscular dystrophy. Aust N Z J Obstet Gynaecol 2002, 42:79–98.

    Article  PubMed  Google Scholar 

  23. Vihola A, Bassez G, Meola G, et al.: Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60:1854–1857.

    PubMed  CAS  Google Scholar 

  24. Gallardo E, Rojas-Garcia R, de Luna N, et al.: Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001, 57:2136–2138.

    PubMed  CAS  Google Scholar 

  25. Neuromuscular Disease Center. Washington University: http://www.neuro.wustl.neuromuscular/musdist/lg.html. Accessed June 2003.

  26. Sewry CA, Brown SC, Mercuri E, et al.: Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol Appl Neurobiol 2001, 27:281–290.

    Article  PubMed  CAS  Google Scholar 

  27. Brockington M, Yuva Y, Prandini P, et al.: Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001, 10:2851–2859.

    Article  PubMed  CAS  Google Scholar 

  28. Adams CR, Figueroa KP, Zu L, et al.: Bethlem myopathy in black Creole pedigree. J Clin Neuromusc Dis 2002, 4:7–10.

    Article  Google Scholar 

  29. Niiyama T, Higuchi I, Suehara M, et al.: Electron microscopic abnormalities of skeletal muscle in patients with collagen VI deficiency in Ullrich’s disease. Acta Neuropathologica 2002, 104:67–71.

    Article  PubMed  CAS  Google Scholar 

  30. Jungbluth H, Muller CR, Halliger-Keller B, et al.: Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology 2002, 59:284–287.

    PubMed  CAS  Google Scholar 

  31. Vogel H: Mitochondrial myopathies and the role of the pathologist in the molecular era. J Neuropathol Exp Neurol 2001, 60:217–227. The author provides a comprehensive review of the historical aspects of mitochondria and human diseases and the diagnosis of mitochondrial myopathies. Histopathologic and biochemical features are emphasized.

    PubMed  CAS  Google Scholar 

  32. Soykan I, Cetinkaya H, Erdem S, et al.: Mitochondrial neurogastrointestinal encephalomyopathy: diagnostic features of two patients. J Clin Gastroenterol 2002, 34:446–448.

    Article  PubMed  Google Scholar 

  33. Rollins S, Prayson RA, McMahon JT, Cohen BH: Diagnostic yield of muscle biopsy in patients with clinical evidence of mitochondrial cytopathy. Am J Clin Pathol 2001, 116:326–330.

    Article  PubMed  CAS  Google Scholar 

  34. Salviati L, Sacconi S, Rasalan M, et al.: Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease. Arch Neurol 2002, 59:862–865.

    Article  PubMed  Google Scholar 

  35. Sugie K, Yamamoto A, Murayama K, et al.: Clinicopathological features of genetically confirmed Danon disease. Neurology 2002, 58:1773–1778.

    PubMed  CAS  Google Scholar 

  36. Takahashi M, Yamamoto A, Takano K, et al.: Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease). Ann Neurol 2002, 52:122–125.

    Article  PubMed  CAS  Google Scholar 

  37. Jääskeläinen SK, Juel VC, Udd B, et al.: Electrophysiological findings in X-linked myopathy with excessive autophagy. Ann Neurol 2002, 51:648–652.

    Article  PubMed  Google Scholar 

  38. Simmons Z, Peterlin BL, Boyer PJ, Towfighi J: Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels. Muscle Nerve 2003, 27:242–244. The authors studied 20 patients who underwent muscle biopsy during the evaluation of elevated creatine kinase in the absence of weakness. Electrodiagnostic studies were normal or revealed only mild abnormalities. Extensive histochemical and biochemical studies yielded a specific diagnosis in six of 20 patients (30%). The disorders were predominantly glycogen- or lipid-storage diseases. The authors discussed whether patients with such clinical and electrodiagnostic findings should undergo muscle biopsy.

    Article  PubMed  Google Scholar 

  39. Merlini L, Carbone I, Capanni C, et al.: Familial isolated hyperCKaemia associated with new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosug Psychiatry 2002, 73:65–67.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Pittsburgh Medical Center, UPMC Presbyterian, 200 Lothrop Street, F878, 15213, Pittsburgh, PA, USA

    David Lacomis MD

Authors
  1. David Lacomis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lacomis, D. The utility of muscle biopsy. Curr Neurol Neurosci Rep 4, 81–86 (2004). https://doi.org/10.1007/s11910-004-0017-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-004-0017-5

Keywords

Search

Navigation